Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.

Andrew Menzies-Gow,Mark Gurnell,Liam G Heaney,Jonathan Corren,Elisabeth H Bel,Jorge Maspero,Timothy Harrison,David J Jackson,David Price,Njira Lugogo,James Kreindler,Annie Burden,Alex de Giorgio-Miller, Sarai Faison,Kelly Padilla,Ubaldo J Martin,Esther Garcia Gil

The European respiratory journal（2022）

引用 6|浏览11

暂无评分

摘要

Most patients successfully maintained maximal OCS reduction while achieving improved asthma control with few exacerbations and maintaining or recovering adrenal function.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要